Philippe Vella
Philippe Vella is the medical director of the Agence nationale de sécurité du médicament (ANSM) in France, who has been vocal about the over-prescription of benzodiazepines such as Xanax, Lexomil, and Temesta. He recently highlighted the alarming statistic that 40% of patients are prescribed these medications for longer than the recommended duration, urging for increased awareness regarding their proper use and associated risks.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| France | 1 | 6.00 | 0.05% | +0% | 65,273,511 | 32,850 | $2,700,000 | 1,359$ |
| Monaco | 1 | 7.00 | 0.08% | +0% | 39,242 | 31 | $7,800 | 6$ |
| Totals | 2 | 65,312,753 | 32,881 | $2,707,800 | 1,365$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Monaco:
Dr. Philippe Vella is the medical director of the ANSM who provided insights on the prescription of benzodiazepines in France.
7
France:
Philippe Vella is the medical director at the ANSM who highlights the issue of long prescription durations for anxiolytics.
6